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Abstract
Objective—Vascular endothelial cells (ECs) are continuously exposed to blood flow that
contributes to the maintenance of vessel structure and function; however, the effect of
hemodynamic forces on transforming growth factor-β (TGF-β) signaling in the endothelium is
poorly described. We examined the potential role of TGF-β signaling in mediating the protective
effects of shear stress on ECs.
Approach and Results—Human umbilical vein endothelial cells (HUVECs) exposed to shear
stress were compared to cells grown under static conditions. Signaling through the TGF-β receptor
ALK5 was inhibited with SB525334. Cells were examined for morphological changes and
harvested for real-time PCR, western blot analysis, apoptosis, proliferation and
immunocytochemistry. Shear stress resulted in ALK5-dependent alignment of HUVECs as well as
attenuation of apoptosis and proliferation compared to static controls. Shear stress lead to an
ALK5-dependent increase in TGF-β3 and Krüppel-like factor 2 (KLF2), phosphorylation of
endothelial nitric oxide synthase (eNOS) and NO release. Addition of the NO donor S-nitroso-N-
acetylpenicillamine (SNAP) rescued the cells from apoptosis due to ALK5 inhibition under shear
stress. Knockdown of TGF-β3, but not TGF-β1, disrupted the HUVEC monolayer and prevented
the induction of KLF2 by shear.
Conclusions—Shear stress of HUVECs induces TGF-β3 signaling and subsequent activation of
KLF2 and NO, and represents a novel role for TGF-β3 in the maintenance of HUVEC homeostasis
in a hemodynamic environment.
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Introduction
Mechanical forces associated with blood flow play an important role in maintaining vessel
structure and function. ECs lining the vasculature are continuously exposed to shear stress as
a result of fluid forces at the blood/EC interface. Shearing of ECs leads to reorganization of
the cytoskeleton, morphological alterations, and production of a variety of substances that
act upon the ECs themselves and surrounding cells.1–3
Coordinated release of growth factors by cells of the vessel wall plays a critical role in
development, stabilization and function of the vasculature. TGF-β is a multifunctional
growth factor that is a well-established modulator of vascular cells.4 Of the three
mammalian TGF-β’s (TGF-β-1, -2, -3), TGF-β1 and TGF-β3 are found in the vasculature.
Structural homology for each isoform among species is ~98% and ~71–76% between the
different isoforms, indicating specific roles for each isoform in vivo,5 though distinct effects
of vascular derived TGF-β1 and TGF-β3 have not been elucidated.
Following its cleavage from an inactive precursor, TGF-β forms a dimer that binds the
TGFβ-receptor II on the endothelial surface. Subsequent recruitment of the TGFβ-receptor I
(TGFβRI – ALK1 or ALK5 in ECs) into a tetrameric complex results in phosphorylation of
the intracellular domain of TGFβRI, and the activation of smad transcription factors. Both
TGF-β1 and TGF-β3 are detected in plasma in the absence of pathology, consistent with a
role for these factors in vessel homeostasis,6–8 as they play for epithelial cells.9 In support of
this notion, it has been shown that preeclampsia, which is characterized by systemic
endothelial dysfunction, multiple end-organ ischemia, hypertension, proteinuria and
increased vascular permeability, is due at least in part to elevated levels of soluble endoglin
(sEng), which neutralizes TGF-β1 and TGF-β3.10 Similarly, experimental systemic
inhibition of TGF-β1 and TGF-β3, achieved by overexpression of sEng, leads to vascular
permeability and perfusion defects as well as apoptosis of both vascular and non-vascular
tissues.11 sEng overexpressing mice also demonstrate an essential role for TGF-β in
maintaining the endothelium in a non-activated state12 and in maintaining microvessel
integrity and function in the retina and choroid plexus.13,14 Previous reports demonstrate
that TGF-β signaling between EC and mural cells participates in vessel stabilization in vivo
and in vitro, and paracrine TGF-β signaling between ECs and surrounding mural cells and
astrocytes is well documented.11,15–17
Members of the KLF family of transcription factors, in particular KLF2, act as central
mediators of shear stress induced changes in EC.18–20 Shear stress-induced KLF2 regulates
the expression of genes important in inflammation, thrombosis, and vessel tone, with an
estimated ~46% of flow-regulated genes downstream of KLF2 induction.21–25 Among the
KLF2-inducible factors regulating vessel tone is eNOS, the well-described shear stress
inducible enzyme that is responsible for formation of nitric oxide (NO). NO, a gas, with a
half-life of a few seconds, acts upon underlying mural cells (pericytes and smooth muscle
cells) to regulate vessel tone and on ECs to modulate inflammatory properties.26–28 The
precise mechanism by which the endothelium senses shear stress to increase both KLF2 and
NO signaling is unclear.
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Experimental inhibition of TGF-β by overexpression of sEng in vivo reveals an important
role for TGF-β in maintaining vessel structure and function in the kidney, retina, mesentery
and choroid plexus,10,12–14 however the role of flow in modulating TGF-β signaling in ECs
is poorly understood. We therefore investigated the effect of shear stress on TGF-β signaling
in ECs and examined the relationship among flow-induced changes in TGF-β, KLF2 and
NO signaling. Our results indicate that protective effect of shear stress on ECs is mediated
via the TGF-β3 signaling and downstream KLF2 and NO signaling.
Methods
Detailed information on the materials and methods, including cell culture, RNA isolation
and real-time–PCR, Western blot analysis and immunofluorescence are described in the
Supplemental Material (available online at http://atvb.ahajournals.org).
Results
Role of TGF-β signaling in the morphological response of HUVECs to shear stress
Confluent monolayers of HUVECs were exposed to shear (10 dynes/cm2) in serum-reduced
medium and cell morphology was examined every 24 hr for three days. Consistent with
previous observations,29 shear stress caused HUVECs to align in the direction of the flow
path, with the cell alignment becoming more pronounced with time (Figure 1). In contrast,
static cells detached from the plate so that after three days only about ~50% of the cells
remained (Figure 1).
To examine the role of TGF-β receptor-ALK5 signaling, HUVECs in a static and
hemodynamic environment were exposed to 10 μM SB525334 in the presence or absence of
shear stress. The effect of SB525334 on static HUVECs was variable, with either no effect
or a slight attenuation of cell loss compared to static controls (Figure 1). Addition of
SB525334 to cells prior to exposure to shear stress led to a modest loss of cells at 24 or 48
hr and a dramatic loss of cells after 72 hr (Figure 1 and Figure 2A). The exposure of cells to
shear stress in the presence of SB525334 (Figure 1) resulted in ~50% loss of cells, though
throughout the well, the degree of cell loss per field of view varied from 0–100%. The
inhibition of ALK4, ALK5 and ALK7 with 10 μM SB431542 did not impair endothelial
morphology (supplemental Figure I). These results reveal that ALK5 is required to maintain
the endothelial monolayer exposed to shear stress.
Effect of TGF-β receptor inhibition on HUVEC proliferation and apoptosis under shear
stress
Consistent with previous reports, exposure of HUVECs to shear stress reduced cell loss
when compared to HUVECs under static conditions.330,31 SB525334 blockade of ALK5
signaling in HUVEC exposed to shear stress led to an increase in cell loss (Figure 2A). As
cell number may reflect changes in cell death and/or proliferation, HUVEC proliferation was
determined using a cell tracer assay. Despite the increased cell number compared to static
control, shear stress decreased HUVEC proliferation by approximately 25%. Addition of
SB525334 further decreased HUVEC proliferation under both static and shear stress
conditions by approximately 40% (Figure 2B and 2C).
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Exposure of HUVEC to shear stress for 72 hr protected HUVEC from apoptosis and
inhibition of TGF-β signaling prevented this protection (Figure 2D). Whereas addition of
SB525334 had no significant effect on the level of apoptosis in cells grown under static
conditions, it led to an approximately five-fold increase in apoptosis compared to shear
stress control cells. Immunofluorescent localization of cleaved caspase-3, a key component
of caspase-dependent apoptosis, revealed that shear stress decreased the cleavage of
caspase-3 in HUVEC (Figure 2E). These findings demonstrate that ALK5 limits endothelial
apoptosis under shear stress conditions.
Effect of shear stress and TGF-β receptor inhibition on TGF-β signaling in EC
In order to assess the effect of shear stress on TGF-β levels in HUVECs, conditioned media
and cell lysates were collected after 72 hr and examined for active and total TGF-β1 and
TGF-β3. Both latent and active TGF-β1 and TGF-β3 were detected in cell lysates, with
active TGF-β3, but not TGF-β1, significantly increased by exposure to shear stress (Figure
3A). Examination of conditioned media revealed that neither total TGF-β1 nor total TGF-β3
were significantly increased under shear stress conditions; neither active TGF-β1 nor TGF-
β3 were detected in media collected. Latent TGF-β1, but not TGF-β3 (latent or active), was
detected in media and the levels were not changed with shear stress (Figure 3A). Real time
PCR revealed that shear stress induced a nearly three-fold increase in TGF-β3; levels of
TGF-β1 mRNA were unchanged. The induction of TGF-β3 by shear stress was blocked by
the addition of SB525334 (Figure 3B). In contrast to increased TGF-β in EC exposed to
shear stress, levels of ALK5 mRNA were unchanged (Supplemental Figure II).
To determine if the shear stress-induced increases in the levels of TGF-β3 resulted in
downstream signaling, intracellular smad2 proteins were examined following 24 hr of shear
stress. Shear stress led to a 2.5-fold increase in the phosphorylation of smad2, in the absence
of any significant changes in total smad2 levels (Figure 3C). Addition of SB525334 reduced
the phosphorylation of smad2 under both static and shear stress conditions without altering
smad2 levels. These results reveal that shear stress of HUVEC increases TGF-β3 and
activates downstream smad2 signaling.
Role of KLF2 and NO in shear stress-induced TGF-β signaling in HUVECs
KLF2 is a key transcriptional regulator of flow-induced changes in ECs.20 To determine if
TGF-β signaling plays a role in flow-induced KLF2 signaling, HUVECs were treated with
SB525334 under static and shear stress conditions and examined for changes in KLF2
mRNA and protein after 24 hr. Shear stress increased KLF2 mRNA (Figure 4A) and protein
(Figures 4B and C), and the addition of SB525334 resulted in a significant (approximately
50%) decrease in both KLF2 mRNA and protein. siRNA targeting of ALK5 also led to a
significant (approximately 30%) reduction of KLF2 mRNA (Supplemental Figure III).
Addition of 0.1 ng/ml TGF-β3 induced KLF2 mRNA, which was partially reversible with
siRNA targeting of ALK5 (Supplemental Figure IV).
NO signaling is the classic mediator of the vasoactive effects of shear stress in ECs.
Exposure of HUVECs to shear stress increased eNOS protein phosphorylation (Serine 1179)
by approximately 2.5 fold after 24 hr (Figure 4D). To determine if TGF-β plays a role in the
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shear stress-induced formation and release of NO from HUVECs, the effect of TGF-β
receptor inhibition was examined. Addition of SB525334 decreased eNOS phosphorylation
in the absence of any changes in total eNOS protein (Figure 4D). Cell supernatants were
examined for the stable NO breakdown product (NOx) using the Griess reaction. Shear
stress of HUVECs resulted in an approximately 2-fold increase in NOx release, which was
significantly inhibited by the addition of SB525334 (Figure 4E).
To determine if the morphological changes and increased apoptosis observed with the
inhibition of TGF-β receptor in shear stressed HUVEC was mediated by decreased NO, the
ability of exogenous NO to rescue the cells from these effects was assessed. Indeed, the
addition of SNP (1 μM) prior to the initiation of shear stress reversed the of TGF-β receptor
inhibition on HUVEC morphology and apoptosis (Figures 5A and B). Taken together, these
results reveal that shear-induced TGF-β3 activation of ALK5 is upstream of KLF2-NO
signaling.
Interaction between KLF2 and TGF-β signaling under shear stress
In order to assess the interaction and signaling sequence between the TGF-β and KLF2
pathways, TGF-β1, TGF-β3 and KLF2 mRNA were knocked down using siRNA pools prior
to exposure to shear stress for 24 hr. The specific siRNA pools decreased the levels of shear
stress induced TGF-β1, TGF-β3, and KLF2 mRNAs, 5-fold, 3-fold and 6-fold, respectively
(Figure 6A, 6B and 6C). Whereas reduction in the levels of TGF-β1 or KLF2 did not
significantly alter TGF-β3 mRNA, knock down of TGF-β3 led to a 4-fold decrease in KLF2
mRNA (Figure 6C).
To determine the relative contribution of TGF-β1, TGF-β3 and KLF2 to the protective
effects of shear stress on HUVECs, each of these proteins was individually knocked down
with siRNA and the cells were then exposed to shear stress for 72 hr. Reduction of TGF-β3
in HUVEC exposed to shear stress led to a disruption of the monolayer that was similar to
that observed with the pharmacologic inhibition of TGF-β receptor (compare Figure 6D and
Figure 5A) whereas the knockdown of TGF-β1 had no effect. KLF2 knockdown also led to a
notable disruption the HUVEC monolayer under shear stress, although not as dramatically
as TGF-β3 knockdown. Addition of SNP (1 μM) completely reversed the effects of KLF2
knockdown, whereas the effect of TGF-β3 suppression was partially rescued with SNP.
While SNP limited HUVEC loss resulting from TGF-β3 inhibition, shear stress-induced
HUVEC alignment was still significantly impaired. The suppression of TGF-β1 levels had
no effect in the presence or absence of SNP (Figure 6D). Taken together, these results reveal
that TGF-β3, not TGF-β1, is upstream of shear stress-induced KLF2.
Discussion
Physiologic shear stress has been shown to be a important protective stimulus for the
endothelium, limiting apoptosis and proliferation while maintaining endothelial quiescence,
and in particular, suppressing the expression of pro-inflammatory proteins.22,32 Our results
are consistent with this function and expand this concept by demonstrating a critical role for
TGF-β signaling in mediating the protective effects of physiologic shear stress. Shear stress
of ECs induces TGF-β3 expression and signal activation via the transmembrane receptor
Walshe et al. Page 5
Arterioscler Thromb Vasc Biol. Author manuscript; available in PMC 2014 November 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
TGF-βRI (ALK5). Pharmacologic inhibition of ALK5 prior to exposure to shear stress for
three days led to a dramatic disruption of the endothelial monolayer and increased cell death.
Specific knockdown of TGF-β3, but not TGF-β1, resulted in similar cell loss over the same
time course. In line with these findings, TGF-β3, but not TGF-β1, was significantly up
regulated under shear stress. These findings demonstrate a novel role for shear stress-
induced TGF-β3.
Cyclic stretch has been reported to upregulate ALK-1, but not ALK-5 or TGF-βRII, in EC
co-cultured with smooth muscle cells, but not in EC in monoculture,33 and other studies
demonstrate that cyclic stretch induces autocrine TGF-β1 via activation of the ERK
pathway.34 Reports of bovine aortic ECs exposed to different types of shear stress revealed
induction of TGF-β1 mRNA via K+ channel activation,35 with laminar and pulsatile flow
having greater effects than oscillatory flow.36 These findings suggest that TGF-β1 plays a
role in atheroprotection since oscillatory flow strongly correlates with atheroprone regions
of the vascular tree. Consistent with our observations recent studies of mouse embryonic EC
reveal shear stress induction of KLF2 is an ALK5 dependent process.37
Prior studies have reported the activation of TGF-β1 by contact of ECs with pericytes or
astrocytes in vivo and induction of TGF-β1 in endothelial cells exposed to shear
stress.35,38,39 However, in our study of EC monocultures exposed to shear stress neither
TGF-β1 nor ALK5 were regulated by shear stress. Rather, shear stress of HUVEC led to
increased levels of TGF-β3 mRNA as well as both active and total protein. TGF-β3 protein
was detected in association with cells but not in the conditioned media. Latent TGF-β1 but
not active was detectable in the conditioned media, and was not changed in response to
shear stress. These findings suggest autocrine/paracrine/juxtacrine roles for TGF-β1 and/or
TGF-β3.
To determine if there was a relationship between TGF-β signaling and flow-induced KLF2
and NO, we specifically targeted each component using siRNA. Knock down of TGF-β3,
but not TGF-β1, prevented the shear stress induction of KLF2. KLF transcription factors are
well-documented mediators of the protective effects of shear stress, and these results
indicate that the induction of TGF-β3 by shear stress is at least partially responsible for the
activation of the KLF2 signaling cascade. TGF-β3 signaling did not mediate shear-induced
KLF4 (supplemental Figure V). KLF2 has been shown to enhance the anti-inflammatory
properties of ECs,40 and we have previously described that inhibition of TGF-β in vivo
using sEng overexpression leads to a pro-inflammatory response of mesenteric ECs, further
supporting the notion that these pathways modulate anti-inflammatory properties of the
endothelium in vivo.12
Previous reports of overexpression of KLF2 in HUVECs under static conditions
demonstrated activation of inhibitory smad signaling, a decrease in smad2 phosphorylation
and decreased TGF-β1 and TGF-β2, but not TGF-β3.41 These results suggest a feedback
mechanism that is consistent with our finding that TGF-β3, but not TGF-β1, induced
expression of KLF2 under shear stress. Moreover, siRNA knockdown of KLF2 did not
significantly alter the levels of TGF-β1 or TGF-β3, demonstrating that KLF2 is downstream
of TGF-β signaling.
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Despite their structural and biological similarities, it is clear that the TGF-β isoforms have
distinct roles. For instance, TGF-β3, but not TGF-β1, protects keratinocytes against
apoptosis in vitro and in vivo.42 Gene transfer of TGF-β3, but not TGF-β1, inhibits
constrictive remodeling and luminal loss after coronary angioplasty.43 The molecular basis
of these differences is unknown, though it may be due, at least in part, to the differences in
binding to TGF-β modulating factors. For example, binding to cell surface and extracellular
matrix heparan sulfate is isoform-specific and is thought to modulate their accessibility and
activity.44 TGF-β1, but not TGF-β3, binds heparan sulfate, potentiating its biological activity
by limiting proteolytic degradation and inactivation by binding to α2-macroglobulin.44
Similarly, TGF-β latency-associated protein (LAP), which is bound to TGF-β in its inactive
form, interacts more effectively with TGF-β3 than with the two other isoforms.45 Recent
studies reveal differences in binding affinity between the TGF-β isoforms and the TGF-β
receptors. TGF-βRII binds TGF-β1 and TGF-β3 with similar affinity due to a conserved
amino acid sequence; however, ALK5 binds TGF-β3 with much higher affinity that TGF-β1.
The differential kinetics of ternary complex assembly persists with binary complexes, with
5-fold greater affinity of TGF-β3/TGF-βRII for ALK5, than TGF-β1/TGF-βRII.46
Developmental studies of large arteries revealed TGF-β3 localization in smooth muscle
progenitor cells, but not in endothelium47 and TGF-β1, but not TGF-β3, mRNA in lung
mesenchymal and endothelial cells.48 Although the role of TGF-β3 in angiogenic processes
has not been elucidate, reports suggest elevated TGF-β3 may promote angiogenesis during
development by increasing Flk-1 and CD31 expression,49 whereas other reports demonstrate
TGF-β1, -β2 and -β3 cooperate to facilitate tube formation.50
In order to assess the mechanism of shear stress-induced TGF-β signaling, we examined the
effects of ALK5 inhibition on the well-documented shear-induced protective EC signaling
components, NO and KLF2.51–53 Shear stress of ECs activates eNOS enzyme activity via
phosphorylation at serine1179, leading to NO release, which acts on the underlying mural
cells to regulate vessel tone.53–55 In addition, NO has been shown to protect ECs from
apoptosis.3,56,57 Our data show that shear stress leads to increased phosphorylation of eNOS
and NO release. These effects were blocked by the inhibition of ALK5 and rescued by the
NO donor SNAP, demonstrating a clear role for the TGF-β signaling in mediating the shear
stress induction of NO and suggesting that the protective effects of TGF-β3 are mediated
largely by NO. Consistent with these findings, eNOS-knockout mice display hypertension,
impaired microvessel function and leukocyte adhesion,58–65 which also occur in sEng
overexpressing mice (systemic TGF-β inhibition),12–14 suggesting that the phenotype in
mice in which TGF-β3 is impaired is at least partially a result of decreased nitric oxide.
siRNA knockdown studies revealed that TGF-β3, but not TGF-β1, was responsible for
protecting ECs exposed to shear stress. Inhibition of ALK5 significantly blocked the
induction of KLF2 mRNA and protein by shear stress, demonstrating that ALK5 is upstream
of KLF2 in the signaling cascade. Inhibition of NO with L-NAME did not effect either
TGF-β3 or KLF2 mRNA (data not shown), indicating that NO is downstream of both ALK5
and KLF2. Addition of exogenous NO fully reversed the effects of ALK5 inhibition;
however, while NO prevented cell loss due to TGF-β3 knockdown, it did not prevent the
loss of EC alignment. These results suggest that the action of TGF-β3 to align EC along the
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flow path is independent of NO signaling. Similarly, knockdown of KLF2 did not result in
the same degree of cell loss as knockdown of TGF-β3 under shear stress, suggesting that
KLF2 is not the only target for TGF-β3 signaling in ECs exposed to flow.
Further investigation of putative NO signaling activators induced by shear/TGF-β3 did not
indicate a role for any of the previously described signaling molecules (pp-PLC-γ, PLC-γ,
HSP90α, PI3k, pp-Akt, Akt, pp-ERK, ERK, pp-p38, p38, JNK, Mek5). Non-biased
proteomic analysis, however, did reveal a number of novel proteins regulated by shear stress
induction of TGF-β3, but not TGF-β1. For example, the level of RhoA was decreased in
sheared ECs, whereas siTGF-β3 treated sheared cells exhibited a significant increase in
RhoA. Interestingly, RhoA has been previously shown to inhibit NO signaling via multiple
pathways.66 ALK1 signaling in ECs stimulates migration and proliferation, both of which
are inhibited upon ALK5/ALK1 complex formation. Proteomic analysis revealed the
differential expression of two proteins that limit ALK1 signaling; shear stress increased EC
PPP1CA (ALK1 inhibitor) and decreased CSNK2B (ALK1 enhancer), effects that were
mediated by the activation of TGF-β3, but not TGF-β1.
We have described a novel effect of shear stress on EC in which the induction of TGF-β3
expression leads to activation of KLF2 and NO signaling. Understanding the mechanisms
underlying this effect sheds light on the potential homeostatic role for plasma TGF-β3 and
should enable targeting of the TGF-β pathway in pathologies in which TGF-β3 signaling is
perturbed such as preeclampsia and cancer.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Non standard abbreviations & and acronyms
ECs Endothelial cells
HUVECs Human umbilical vein endothelial cells
KLF Krüppel-like factor
eNOS endothelial nitric oxide synthase
SNAP S-nitroso-N-acetylpenicillamine
sEng soluble endoglin
NO nitric oxide
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Significance
Vascular endothelial cells (ECs) are continuously exposed to blood flow that contributes
to the maintenance of vessel structure and function; however, the effect of hemodynamic
forces on TGF-β signaling in the endothelium is not well understood. We have described
a novel effect of shear stress on EC, in which the induction of TGF-β3 expression leads
to activation of KLF2 and NO signaling, which are known to limit endothelial
dysfunction and maintain endothelial homeostasis. The induction of TGF-β by shear
stress was specific to TGF-β3 - did not effect TGF-β1, thus revealing their differential
regulation. Each of the TGF-β’s is strongly conserved across species, however their
distinct roles are poorly described. Understanding the mechanisms underlying these
changes sheds light on the potential homeostatic role of plasma TGF-β3 and should
enable targeting the TGF-β pathway in pathologies in which TGF-β3 signaling is
perturbed such as preeclampsia and cancer
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Figure 1.
Effects of ALK5 inhibition on shear stress-induced changes in HUVEC morphology. Shear
stress led to HUVEC alignment along the flow path (arrow). Treatment of cells with the
ALK5 inhibitor, SB525334, led to a disruption of the HUVEC monolayer after 72 hr
(arrowhead).
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Figure 2.
(A) Shear stress of HUVEC limited the decrease in cell numbers compared to cells grown
under static conditions; SB525334 reduced this protective effect. (B)(C) Shear stress
decreased HUVEC proliferation; SB525334 further decreased proliferation. (D) Shear stress
decreased HUVEC apoptosis and caspase 3 activation (E) and is dependent on ALK-5.
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Figure 3.
(A) TGF-β1 was detected in HUVEC conditioned media. Shear stress increased active and
latent cell associated TGF-β3, but had no effect on levels of TGF-β1. (B) Shear stress
increased TGF-β3 mRNA and phosphorylation of smad2 (C). Addition of SB525334
inhibited the phosphorylation of smad2.
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Figure 4.
Shear stress increases HUVEC KLF2 mRNA (A) and protein (B) (C); this effect was
partially reversed by the inhibition of ALK5. Shear stress increased phosphorylation of
eNOS protein (D) (E) and release of NOx (F), which was blocked with inhibition of ALK5.
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Figure 5.
(A) SB525334 prevented the protective effects of shear stress on HUVECs at 72 hr and
addition of 1 uM SNAP reversed this effect. (B) FACs analysis of apoptotic HUVECs
revealed that the addition of SNAP prevented the increase in HUVEC apoptosis caused by
the blockade of ALK5.
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Figure 6.
mRNA levels of (A) TGF-β1, (B) TGF-β3, and (C) KLF2 following siRNA treatment. (D)
siTGF-β3 significantly disrupted the HUVEC monolayer. SNP rescued this cell loss, but not
loss of cell alignment. siKLF-2 partially impaired HUVECs morphology, which was fully
rescued by the addition of exogenous SNP.
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